Elixxer Non Current Liabilities Total from 2010 to 2024

Stocks . Canada . 
Stock . Elixxer
ELXR Stock  CAD 1.15  0.00  0.00%   
Elixxer Non Current Liabilities Total yearly trend continues to be fairly stable with very little volatility. Non Current Liabilities Total is likely to outpace its year average in 2024. During the period from 2010 to 2024, Elixxer Non Current Liabilities Total regression line of quarterly data had mean square error of 1.6 T and geometric mean of 0.00. View All Fundamentals
 
Non Current Liabilities Total  
First Reported
2010-12-31
Previous Quarter
4.2 M
Current Value
4.4 M
Quarterly Volatility
1.7 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Elixxer financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Elixxer's main balance sheet or income statement drivers, such as Interest Income of 8.9 K, Interest Expense of 1.5 M or Selling General Administrative of 3.4 M, as well as many indicators such as . Elixxer financial statements analysis is a perfect complement when working with Elixxer Valuation or Volatility modules.
  
This module can also supplement various Elixxer Technical models . Check out the analysis of Elixxer Correlation against competitors.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Elixxer Stock Analysis

When running Elixxer's price analysis, check to measure Elixxer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elixxer is operating at the current time. Most of Elixxer's value examination focuses on studying past and present price action to predict the probability of Elixxer's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elixxer's price. Additionally, you may evaluate how the addition of Elixxer to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY